From e5c76108e4579ebfbef0e421f68bef6862c30e33 Mon Sep 17 00:00:00 2001 From: Yasset Perez-Riverol Date: Tue, 27 Aug 2024 10:48:06 +0100 Subject: [PATCH] more fixes to datasets --- .../MSV000078494/MSV000078494.sdrf.tsv | 192 ++--- .../MSV000078535/MSV000078535.sdrf.tsv | 88 +- .../MSV000078555/MSV000078555.sdrf.tsv | 352 ++++---- .../MSV000080451/MSV000080451.sdrf.tsv | 142 ++-- .../PXD003469/PXD003469.sdrf.tsv | 18 +- .../PXD012307/PXD012307.sdrf.tsv | 2 +- .../PXD014557/PXD014557.sdrf.tsv | 802 +++++++++--------- .../PXD019185_PXD018883.sdrf.tsv | 26 +- .../PXD023707/PXD023707.sdrf.tsv | 6 +- 9 files changed, 814 insertions(+), 814 deletions(-) diff --git a/annotated-projects/MSV000078494/MSV000078494.sdrf.tsv b/annotated-projects/MSV000078494/MSV000078494.sdrf.tsv index a5cd4ee6..a4283788 100644 --- a/annotated-projects/MSV000078494/MSV000078494.sdrf.tsv +++ b/annotated-projects/MSV000078494/MSV000078494.sdrf.tsv @@ -1,97 +1,97 @@ source name characteristics[biological replicate] characteristics[organism] characteristics[organism part] characteristics[xenograft] characteristics[cell type] characteristics[cell line] characteristics[age] characteristics[disease] characteristics[enrichment process] assay name technology type comment[cleavage agent details] comment[cleavage agent details] comment[cleavage agent details] comment[fractionation method] comment[fraction identifier] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[instrument] comment[label] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[tool metadata] comment[file uri] comment[data file] factor value[disease] -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 1 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091103_CO_5555_FP/W091103_nCO_5555_FP_rafkt_ft8_cc_01.RAW W091103_nCO_5555_FP_rafkt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 2 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091103_LU_5555_FP/W091103_nLU_5555_FP_rafkt_ft8_cc_01.RAW W091103_nLU_5555_FP_rafkt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 3 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_01_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_01_OGE_raflt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 4 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_02_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_02_OGE_raflt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 5 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_03_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_03_OGE_raflt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 6 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_04_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_04_OGE_raflt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 7 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_05_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_05_OGE_raflt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 8 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_06_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_06_OGE_raflt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 9 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_07_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_07_OGE_raflt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 10 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_08_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_08_OGE_raflt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 11 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_09_10_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_09_10_OGE_raflt_ft8_cc_01.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 12 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_11_OGE_raflt_ft8_cc_02.RAW W091119_LU_5555_11_OGE_raflt_ft8_cc_02.RAW normal -lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 13 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_12_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_12_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 14 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_01_OGE_raflt_ft8_cc_01.RAW W091121_CO_5555_01_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 15 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_02_OGE_raflt_ft8_cc_01.RAW W091121_CO_5555_02_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 16 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_03_OGE_raflt_ft8_cc_01.RAW W091121_CO_5555_03_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 18 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_05_OGE_raflt_ft8_cc_01.RAW W091121_CO_5555_05_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 17 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_04_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_04_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 19 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_06_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_06_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 20 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_07_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_07_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 21 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_08_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_08_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 22 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_09_10_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_09_10_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 23 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_11_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_11_OGE_raflt_ft8_cc_01.RAW normal -colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 24 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_12_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_12_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 25 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091103_nCO_5557_FP/W091103_nCO_5557_FP_rafkt_ft8_cc_01.RAW W091103_nCO_5557_FP_rafkt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 26 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091103_nLU_5557_FP/W091103_nLU_5557_FP_rafkt_ft8_cc_01.RAW W091103_nLU_5557_FP_rafkt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 27 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_01_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_01_OGE_raflt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 28 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_02_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_02_OGE_raflt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 29 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_03_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_03_OGE_raflt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 30 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_04_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_04_OGE_raflt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 31 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_05_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_05_OGE_raflt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 32 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_06_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_06_OGE_raflt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 33 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_07_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_07_OGE_raflt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 34 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_08_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_08_OGE_raflt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 35 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_09_10_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_09_10_OGE_raflt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 36 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_11_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_11_OGE_raflt_ft8_cc_01.RAW normal -lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 37 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_12_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_12_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 38 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_01_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_01_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 39 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_02_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_02_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 40 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_03_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_03_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 41 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_04_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_04_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 42 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_05_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_05_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 43 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_06_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_06_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 44 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_07_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_07_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 45 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_08_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_08_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 46 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_09_10_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_09_10_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 47 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_11_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_11_OGE_raflt_ft8_cc_01.RAW normal -colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 48 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_12_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_12_OGE_raflt_ft8_cc_01.RAW normal -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 49 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091103_XG_A375_1A/W091103_XG_A375_1A_FP_rafkt_ft8_cc_01.RAW W091103_XG_A375_1A_FP_rafkt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 50 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_01_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_01_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 51 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_02_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_02_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 52 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_03_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_03_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 53 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_04_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_04_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 54 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_05_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_05_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 55 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_06_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_06_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 56 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_07_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_07_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 57 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_08_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_08_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 58 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_09_10_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_09_10_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 59 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_11_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_11_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 60 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_12_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_12_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 61 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091103_XG_A375_3A/W091103_XG_A375_3A_FP_rafkt_ft8_cc_01.RAW W091103_XG_A375_3A_FP_rafkt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 62 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_01_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_01_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 63 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_02_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_02_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 64 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_03_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_03_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 65 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_04_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_04_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 66 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_05_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_05_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 67 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_06_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_06_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 68 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_07_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_07_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 69 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_08_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_08_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 70 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_09_10_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_09_10_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 71 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_11_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_11_OGE_raflt_ft8_cc_01.RAW melanoma -A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 72 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_12_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_12_OGE_raflt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 73 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100120_XG_MA2_2B/W100120_XG_MA2_2B_FP_rafkt_ft8_cc_01.RAW W100120_XG_MA2_2B_FP_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 74 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_01_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_01_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 75 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_02_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_02_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 76 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_03_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_03_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 77 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_04_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_04_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 78 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_05_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_05_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 79 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_06_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_06_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 80 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_07_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_07_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 81 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_08_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_08_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 82 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_09_10_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_09_10_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 83 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_11_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_11_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 84 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_12_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_12_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 85 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100120_XG_MA2_3A/W100120_XG_MA2_3A_FP_rafkt_ft8_cc_01.RAW W100120_XG_MA2_3A_FP_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 86 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_01_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_01_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 87 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_02_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_02_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 88 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_03_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_03_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 89 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_04_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_04_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 90 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_05_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_05_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 91 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_06_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_06_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 92 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_07_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_07_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 93 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_08_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_08_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 94 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_09_10_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_09_10_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 95 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_11_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_11_rafkt_ft8_cc_01.RAW melanoma -MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 96 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_12_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_12_rafkt_ft8_cc_01.RAW melanoma \ No newline at end of file +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 1 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091103_CO_5555_FP/W091103_nCO_5555_FP_rafkt_ft8_cc_01.RAW W091103_nCO_5555_FP_rafkt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 2 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091103_LU_5555_FP/W091103_nLU_5555_FP_rafkt_ft8_cc_01.RAW W091103_nLU_5555_FP_rafkt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 3 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_01_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_01_OGE_raflt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 4 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_02_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_02_OGE_raflt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 5 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_03_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_03_OGE_raflt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 6 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_04_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_04_OGE_raflt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 7 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_05_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_05_OGE_raflt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 8 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_06_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_06_OGE_raflt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 9 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_07_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_07_OGE_raflt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 10 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_08_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_08_OGE_raflt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 11 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_09_10_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_09_10_OGE_raflt_ft8_cc_01.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 12 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_11_OGE_raflt_ft8_cc_02.RAW W091119_LU_5555_11_OGE_raflt_ft8_cc_02.RAW normal +lung sample 1 1 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 13 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_12_OGE_raflt_ft8_cc_01.RAW W091119_LU_5555_12_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 14 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_01_OGE_raflt_ft8_cc_01.RAW W091121_CO_5555_01_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 15 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_02_OGE_raflt_ft8_cc_01.RAW W091121_CO_5555_02_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 16 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_03_OGE_raflt_ft8_cc_01.RAW W091121_CO_5555_03_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 18 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_05_OGE_raflt_ft8_cc_01.RAW W091121_CO_5555_05_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 17 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_04_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_04_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 19 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_06_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_06_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 20 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_07_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_07_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 21 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_08_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_08_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 22 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_09_10_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_09_10_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 23 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_11_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_11_OGE_raflt_ft8_cc_01.RAW normal +colon sample 1 1 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 24 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_12_OGE_raflt_ft8_cc_01.RAW W091123_CO_5555_12_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 25 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091103_nCO_5557_FP/W091103_nCO_5557_FP_rafkt_ft8_cc_01.RAW W091103_nCO_5557_FP_rafkt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 26 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091103_nLU_5557_FP/W091103_nLU_5557_FP_rafkt_ft8_cc_01.RAW W091103_nLU_5557_FP_rafkt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 27 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_01_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_01_OGE_raflt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 28 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_02_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_02_OGE_raflt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 29 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_03_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_03_OGE_raflt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 30 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_04_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_04_OGE_raflt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 31 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_05_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_05_OGE_raflt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 32 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_06_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_06_OGE_raflt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 33 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_07_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_07_OGE_raflt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 34 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_08_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_08_OGE_raflt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 35 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_09_10_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_09_10_OGE_raflt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 36 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_11_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_11_OGE_raflt_ft8_cc_01.RAW normal +lung sample 2 2 mus musculus lung not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 37 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_12_OGE_raflt_ft8_cc_01.RAW W091218_LU_5557_12_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 38 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_01_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_01_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 39 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_02_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_02_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 40 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_03_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_03_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 41 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_04_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_04_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 42 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_05_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_05_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 43 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_06_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_06_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 44 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_07_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_07_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 45 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_08_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_08_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 46 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_09_10_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_09_10_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 47 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_11_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_11_OGE_raflt_ft8_cc_01.RAW normal +colon sample 2 2 mus musculus colon not applicable not available not available 8w-12w normal NT=Extraction purification;AC=NCIT:C113061 run 48 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_12_OGE_raflt_ft8_cc_01.RAW W091219_CO_5557_12_OGE_raflt_ft8_cc_01.RAW normal +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 49 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091103_XG_A375_1A/W091103_XG_A375_1A_FP_rafkt_ft8_cc_01.RAW W091103_XG_A375_1A_FP_rafkt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 50 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_01_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_01_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 51 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_02_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_02_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 52 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_03_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_03_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 53 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_04_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_04_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 54 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_05_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_05_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 55 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_06_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_06_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 56 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_07_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_07_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 57 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_08_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_08_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 58 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_09_10_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_09_10_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 59 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_11_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_11_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 60 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_12_OGE_raflt_ft8_cc_01.RAW W091211_XG_A375_1A_12_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 61 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091103_XG_A375_3A/W091103_XG_A375_3A_FP_rafkt_ft8_cc_01.RAW W091103_XG_A375_3A_FP_rafkt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 62 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_01_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_01_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 63 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_02_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_02_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 64 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_03_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_03_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 65 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_04_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_04_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 66 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_05_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_05_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 67 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_06_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_06_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 68 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_07_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_07_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 69 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_08_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_08_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 70 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_09_10_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_09_10_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 71 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_11_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_11_OGE_raflt_ft8_cc_01.RAW melanoma +A375 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell A375 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 72 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_12_OGE_raflt_ft8_cc_01.RAW W091212_XG_A375_3A_12_OGE_raflt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 73 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100120_XG_MA2_2B/W100120_XG_MA2_2B_FP_rafkt_ft8_cc_01.RAW W100120_XG_MA2_2B_FP_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 74 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_01_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_01_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 75 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_02_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_02_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 76 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_03_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_03_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 77 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_04_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_04_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 78 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_05_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_05_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 79 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_06_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_06_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 80 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_07_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_07_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 81 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_08_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_08_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 82 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_09_10_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_09_10_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 83 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_11_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_11_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 1 1 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 84 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_12_rafkt_ft8_cc_01.RAW W100212_XG_MA2_2B_OGE_12_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 85 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100120_XG_MA2_3A/W100120_XG_MA2_3A_FP_rafkt_ft8_cc_01.RAW W100120_XG_MA2_3A_FP_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 86 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_01_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_01_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 87 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_02_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_02_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 88 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_03_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_03_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 89 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_04_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_04_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 90 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_05_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_05_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 91 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_06_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_06_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 92 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_07_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_07_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 93 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_08_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_08_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 94 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_09_10_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_09_10_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 95 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_11_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_11_rafkt_ft8_cc_01.RAW melanoma +MA2 sample 2 2 homo sapiens not available cancer cell line grown in mice tumor cell MA2 54y melanoma NT=Extraction purification;AC=NCIT:C113061 run 96 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_12_rafkt_ft8_cc_01.RAW W100222_XG_MA2_3A_OGE_12_rafkt_ft8_cc_01.RAW melanoma \ No newline at end of file diff --git a/annotated-projects/MSV000078535/MSV000078535.sdrf.tsv b/annotated-projects/MSV000078535/MSV000078535.sdrf.tsv index d7c7fcb0..437f88ee 100644 --- a/annotated-projects/MSV000078535/MSV000078535.sdrf.tsv +++ b/annotated-projects/MSV000078535/MSV000078535.sdrf.tsv @@ -1,45 +1,45 @@ source name characteristics[biological replicate] characteristics[organism] characteristics[organism part] characteristics[xenograft] characteristics[cell type] characteristics[cell line] characteristics[age] characteristics[sex] characteristics[disease] characteristics[enrichment process] characteristics[phenotype] assay name technology type comment[cleavage agent details] comment[cleavage agent details] comment[cleavage agent details] comment[fractionation method] comment[fraction identifier] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[instrument] comment[label] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[tool metadata] comment[file uri] comment[data file] factor value[phenotype] -LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 1 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE01_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE01_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 2 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE02_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE02_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 3 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE03_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE03_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 4 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE04_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE04_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 5 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE05_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE05_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 6 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE06_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE06_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 7 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE07_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE07_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 8 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE08_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE08_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 9 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE09_10_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE09_10_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 10 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE11_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE11_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 11 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE12_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE12_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 12 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE01_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE01_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 13 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE02_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE02_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 14 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE03_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE03_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 15 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE04_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE04_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 16 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE05_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE05_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 17 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE06_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE06_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 18 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE07_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE07_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 19 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE08_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE08_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 20 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE09_10_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE09_10_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 21 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE11_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE11_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 22 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE12_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE12_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 23 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101001_MDAMB231_1_OGE01_rafkt_ft8_cc_01.RAW D101001_MDAMB231_1_OGE01_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 24 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE02_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE02_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 25 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE03_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE03_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 26 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE04_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE04_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 27 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE05_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE05_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 28 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE06_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE06_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 29 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE07_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE07_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 30 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE08_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE08_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 31 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE09_10_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE09_10_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 32 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE11_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE11_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 33 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE12_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE12_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 34 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE01_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE01_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 35 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE02_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE02_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 36 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE03_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE03_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 37 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE04_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE04_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 38 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE05_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE05_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 39 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE06_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE06_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 40 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE07_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE07_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 41 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE08_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE08_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 42 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE09_10_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE09_10_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 43 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE11_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE11_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 -MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 44 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE12_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE12_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 \ No newline at end of file +LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 1 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE01_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE01_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 2 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE02_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE02_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 3 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE03_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE03_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 4 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE04_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE04_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 5 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE05_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE05_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 6 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE06_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE06_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 7 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE07_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE07_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 8 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE08_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE08_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 9 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE09_10_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE09_10_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_3 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 10 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE11_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE11_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 11 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE12_rafkt_ft8_cc_01.RAW W101005_LM2_3_OGE12_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 12 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE01_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE01_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 13 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE02_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE02_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 14 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE03_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE03_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 15 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE04_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE04_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 16 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE05_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE05_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 17 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE06_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE06_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 18 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE07_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE07_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 19 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE08_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE08_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 20 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE09_10_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE09_10_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 21 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE11_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE11_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +LM2_1 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=increased metastatic potential;AC=MP:0001272 run 22 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE12_rafkt_ft8_cc_01.RAW W101023_LM2_1_OGE12_rafkt_ft8_cc_01.RAW NT=increased metastatic potential;AC=MP:0001272 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 23 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101001_MDAMB231_1_OGE01_rafkt_ft8_cc_01.RAW D101001_MDAMB231_1_OGE01_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 24 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE02_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE02_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 25 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE03_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE03_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 26 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE04_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE04_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 27 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE05_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE05_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 28 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE06_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE06_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 29 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE07_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE07_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 30 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE08_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE08_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 31 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE09_10_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE09_10_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 32 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE11_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE11_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_1 1 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 33 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE12_rafkt_ft8_cc_01.RAW D101003_MDAMB231_1_OGE12_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 34 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE01_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE01_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 35 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE02_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE02_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 36 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE03_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE03_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 37 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE04_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE04_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 38 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE05_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE05_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 39 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE06_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE06_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 40 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE07_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE07_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 41 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE08_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE08_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 42 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE09_10_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE09_10_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 43 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE11_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE11_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 +MDAMB231_2 2 homo sapiens mammary gland cancer cell line grown in mice mammary gland epithelial cell MDAMB231 51y F adenocarcinoma NT= Extraction purification;AC=NCIT:C113061 NT=decreased metastatic potential;AC=MP:0001273 run 44 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap;AC=MS:1000449 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE12_rafkt_ft8_cc_01.RAW W101022_MDAMB231_2_OGE12_rafkt_ft8_cc_01.RAW NT=decreased metastatic potential;AC=MP:0001273 \ No newline at end of file diff --git a/annotated-projects/MSV000078555/MSV000078555.sdrf.tsv b/annotated-projects/MSV000078555/MSV000078555.sdrf.tsv index 0babe748..abc81c34 100644 --- a/annotated-projects/MSV000078555/MSV000078555.sdrf.tsv +++ b/annotated-projects/MSV000078555/MSV000078555.sdrf.tsv @@ -1,177 +1,177 @@ source name characteristics[biological replicate] characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[age] characteristics[ancestry category] characteristics[sex] characteristics[disease] characteristics[individual] characteristics[pool] characteristics[enrichment process] assay name technology type comment[cleavage agent details] comment[cleavage agent details] comment[cleavage agent details] comment[fractionation method] comment[fraction identifier] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[instrument] comment[label] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[tool metadata] comment[file uri] comment[data file] factor value[disease] -Liver Metastasis Pateint 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 1 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE08_rafkt_ft8dt_cc_01.RAW D110729_MGH_540_OGE08_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 2 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 _10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE09_10_rafkt_ft8dt_cc_01.RAW D110729_MGH_540_OGE09_10_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 3 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE11_rafkt_ft8dt_cc_01.RAW D110729_MGH_540_OGE11_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 4 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE12_rafkt_ft8dt_cc_01.RAW D110729_MGH_540_OGE12_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 5 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE01_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE01_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 6 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE02_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE02_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 7 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE03_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE03_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 8 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE04_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE04_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 9 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE05_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE05_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 10 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE06_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE06_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 11 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE07_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE07_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 12 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE01_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE01_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 13 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE02_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE02_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 14 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE03_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE03_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 15 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE04_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE04_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 16 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE05_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE05_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 17 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE06_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE06_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 18 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE07_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE07_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 19 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE08_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE08_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 20 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE09_10_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE09_10_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 21 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE11_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE11_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 22 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE12_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE12_rafkt_ft8_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 23 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110728_MGH_446A_OGE01_rafkt_ft8dt_cc_01.RAW D110728_MGH_446A_OGE01_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 24 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110728_MGH_446A_OGE02_rafkt_ft8dt_cc_01.RAW D110728_MGH_446A_OGE02_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 25 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE03_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE03_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 26 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE04_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE04_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 27 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE05_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE05_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 28 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE06_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE06_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 29 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE07_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE07_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 30 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE08_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE08_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 31 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE09_10_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE09_10_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 32 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE11_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE11_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 33 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE12_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE12_rafkt_ft8dt_cc_01.RAW normal -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 34 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE01_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE01_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 35 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE02_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE02_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 36 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE03_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE03_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 37 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE04_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE04_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 38 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE05_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE05_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 39 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE06_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE06_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 40 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE07_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE07_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 41 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE08_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE08_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 42 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE09_10_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE09_10_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 43 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE11_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE11_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 44 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE12_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE12_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 45 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE09_10_rafkt_ft8dt_cc_01.RAW D111129_MGH_445a_OGE09_10_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 46 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE11_rafkt_ft8dt_cc_01.RAW D111129_MGH_445a_OGE11_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 47 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE12_rafkt_ft8dt_cc_01.RAW D111129_MGH_445a_OGE12_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 48 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE01_rafkt_ft8dt_cc_01.RAW D111130_MGH_445a_OGE01_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 49 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE02_rafkt_ft8dt_cc_01.RAW D111130_MGH_445a_OGE02_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 50 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE03_rafkt_ft8dt_cc_01.RAW D111130_MGH_445a_OGE03_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 51 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111201_MGH_445a_OGE04_rafkt_ft8dt_cc_01.RAW D111201_MGH_445a_OGE04_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 52 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111201_MGH_445a_OGE05_rafkt_ft8dt_cc_01.RAW D111201_MGH_445a_OGE05_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 53 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE06_rafkt_ft8dt_cc_01.RAW D111202_MGH_445a_OGE06_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 54 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE07_rafkt_ft8dt_cc_01.RAW D111202_MGH_445a_OGE07_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 55 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE08_rafkt_ft8dt_cc_01.RAW D111202_MGH_445a_OGE08_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 56 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE01_rafkt_ft8dt_cc_01.RAW D111202_MGH_445_OGE01_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 57 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE02_rafkt_ft8dt_cc_01.RAW D111202_MGH_445_OGE02_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 58 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE03_rafkt_ft8dt_cc_01.RAW D111202_MGH_445_OGE03_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 59 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE04_rafkt_ft8dt_cc_01.RAW D111202_MGH_445_OGE04_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 60 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE05_rafkt_ft8dt_cc_01.RAW D111202_MGH_445_OGE05_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 61 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10_11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE010_11_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE010_11_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 62 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE06_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE06_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 63 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE07_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE07_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 64 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE08_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE08_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 65 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE09_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE09_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 66 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE12_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE12_rafkt_ft8dt_cc_01.RAW colon carcinoma -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 67 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE01_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE01_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 68 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE02_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE02_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 69 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE03_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE03_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 70 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE04_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE04_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 71 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE05_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE05_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 72 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE06_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE06_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 73 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE07_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE07_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 74 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE08_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE08_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 75 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE09_10_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE09_10_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 76 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE11_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE11_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 77 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE12_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE12_rafkt_ft8dt_cc_01.RAW normal -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 78 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE01_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE01_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 79 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE02_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE02_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 80 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE03_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE03_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 81 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE04_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE04_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 82 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE05_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE05_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 83 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE06_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE06_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 84 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE07_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE07_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 85 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE08_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE08_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 86 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE09_10_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE09_10_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 87 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE11_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE11_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 88 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE12_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE12_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 89 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE08_rafkt_ft8dt_cc_01.RAW D120217_MGH_2205A_OGE08_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 90 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE09_10_rafkt_ft8dt_cc_01.RAW D120217_MGH_2205A_OGE09_10_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 91 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE11_rafkt_ft8dt_cc_01.RAW D120217_MGH_2205A_OGE11_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 92 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE12_rafkt_ft8dt_cc_01.RAW D120217_MGH_2205A_OGE12_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 93 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE01_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE01_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 94 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE02_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE02_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 95 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE03_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE03_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 96 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE04_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE04_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 97 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE05_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE05_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 98 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE06_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE06_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 99 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE07_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE07_rafkt_ft8dt_cc_01.RAW colon carcinoma -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 100 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE01_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE01_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 101 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE02_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE02_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 102 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE03_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE03_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 103 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE04_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE04_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 104 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE05_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE05_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 105 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE06_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE06_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 106 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE07_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE07_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 107 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE08_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE08_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 108 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE09_10_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE09_10_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 109 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE11_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE11_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 110 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE12_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE12_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 111 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE01_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE01_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 112 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE02_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE02_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 113 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE03_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE03_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 114 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE04_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE04_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 115 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE05_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE05_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 116 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE06_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE06_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 117 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE07_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE07_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 118 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE08_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE08_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 119 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE09_10_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE09_10_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 120 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE11_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE11_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 121 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE12_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE12_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 122 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE03_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE03_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 123 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE04_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE04_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 124 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE05_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE05_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 125 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE06_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE06_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 126 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE07_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE07_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 127 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE08_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE08_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 128 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 129 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE11_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE11_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 130 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE12_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE12_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 131 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120419_MGH_HS1_NLi_OGE01_rafkt_ft8dt_cc_01.RAW D120419_MGH_HS1_NLi_OGE01_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 132 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120419_MGH_HS1_NLi_OGE02_rafkt_ft8dt_cc_01.RAW D120419_MGH_HS1_NLi_OGE02_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 133 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE01_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE01_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 134 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE02_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE02_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 135 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE03_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE03_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 136 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE04_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE04_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 137 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE05_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE05_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 138 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE06_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE06_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 139 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE07_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE07_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 140 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE08_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE08_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 141 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 142 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE11_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE11_rafkt_ft8dt_cc_01.RAW normal -Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 143 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE12_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE12_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 144 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE01_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE01_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 145 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE02_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE02_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 146 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE03_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE03_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 147 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE04_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE04_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 148 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE05_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE05_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 149 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE06_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE06_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 150 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE07_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE07_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 151 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE08_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE08_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 152 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE09_10_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE09_10_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 153 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE11_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE11_rafkt_ft8dt_cc_01.RAW normal -Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 154 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE12_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE12_rafkt_ft8dt_cc_01.RAW normal -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 155 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE01_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE01_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 156 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE02_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE02_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 157 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE03_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE03_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 158 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE04_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE04_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 159 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE05_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE05_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 160 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE06_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE06_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 161 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE07_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE07_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 162 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE08_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE08_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 163 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE09_10_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE09_10_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 164 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE11_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE11_rafkt_ft8dt_cc_01.RAW colon carcinoma -Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 165 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE12_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE12_rafkt_ft8dt_cc_01.RAW colon carcinoma -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 166 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE01_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE01_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 167 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE02_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE02_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 168 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE03_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE03_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 169 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE04_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE04_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 170 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE05_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE05_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 171 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE06_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE06_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 172 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE07_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE07_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 173 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE08_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE08_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 174 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE09_10_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE09_10_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 175 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE11_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE11_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver -Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 176 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE12_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE12_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver \ No newline at end of file +Liver Metastasis Pateint 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 1 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE08_rafkt_ft8dt_cc_01.RAW D110729_MGH_540_OGE08_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 2 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 _10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE09_10_rafkt_ft8dt_cc_01.RAW D110729_MGH_540_OGE09_10_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 3 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE11_rafkt_ft8dt_cc_01.RAW D110729_MGH_540_OGE11_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 4 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE12_rafkt_ft8dt_cc_01.RAW D110729_MGH_540_OGE12_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 5 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE01_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE01_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 6 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE02_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE02_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 7 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE03_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE03_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 8 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE04_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE04_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 9 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE05_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE05_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 10 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE06_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE06_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 11 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE07_rafkt_ft8dt_cc_01.RAW D110731_MGH_540_OGE07_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 12 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE01_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE01_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 13 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE02_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE02_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 14 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE03_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE03_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 15 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE04_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE04_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 16 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE05_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE05_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 17 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE06_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE06_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 18 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE07_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE07_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 19 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE08_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE08_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 20 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE09_10_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE09_10_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 21 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE11_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE11_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 22 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE12_rafkt_ft8_cc_01.RAW D110801_MGH_446_OGE12_rafkt_ft8_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 23 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110728_MGH_446A_OGE01_rafkt_ft8dt_cc_01.RAW D110728_MGH_446A_OGE01_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 24 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110728_MGH_446A_OGE02_rafkt_ft8dt_cc_01.RAW D110728_MGH_446A_OGE02_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 25 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE03_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE03_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 26 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE04_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE04_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 27 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE05_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE05_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 28 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE06_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE06_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 29 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE07_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE07_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 30 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE08_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE08_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 31 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE09_10_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE09_10_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 32 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE11_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE11_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available normal 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 33 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE12_rafkt_ft8dt_cc_01.RAW D110806_MGH_446A_OGE12_rafkt_ft8dt_cc_01.RAW normal +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 34 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE01_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE01_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 35 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE02_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE02_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 36 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE03_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE03_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 37 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE04_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE04_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 38 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE05_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE05_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 39 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE06_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE06_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 40 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE07_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE07_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 41 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE08_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE08_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 42 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE09_10_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE09_10_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 43 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE11_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE11_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 1 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 44 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE12_rafkt_ft8dt_cc_01.RAW D111019_MGH_540a_OGE12_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 45 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE09_10_rafkt_ft8dt_cc_01.RAW D111129_MGH_445a_OGE09_10_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 46 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE11_rafkt_ft8dt_cc_01.RAW D111129_MGH_445a_OGE11_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 47 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE12_rafkt_ft8dt_cc_01.RAW D111129_MGH_445a_OGE12_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 48 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE01_rafkt_ft8dt_cc_01.RAW D111130_MGH_445a_OGE01_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 49 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE02_rafkt_ft8dt_cc_01.RAW D111130_MGH_445a_OGE02_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 50 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE03_rafkt_ft8dt_cc_01.RAW D111130_MGH_445a_OGE03_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 51 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111201_MGH_445a_OGE04_rafkt_ft8dt_cc_01.RAW D111201_MGH_445a_OGE04_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 52 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111201_MGH_445a_OGE05_rafkt_ft8dt_cc_01.RAW D111201_MGH_445a_OGE05_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 53 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE06_rafkt_ft8dt_cc_01.RAW D111202_MGH_445a_OGE06_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 54 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE07_rafkt_ft8dt_cc_01.RAW D111202_MGH_445a_OGE07_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 55 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE08_rafkt_ft8dt_cc_01.RAW D111202_MGH_445a_OGE08_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 56 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE01_rafkt_ft8dt_cc_01.RAW D111202_MGH_445_OGE01_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 57 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE02_rafkt_ft8dt_cc_01.RAW D111202_MGH_445_OGE02_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 58 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE03_rafkt_ft8dt_cc_01.RAW D111202_MGH_445_OGE03_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 59 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE04_rafkt_ft8dt_cc_01.RAW D111202_MGH_445_OGE04_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 60 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE05_rafkt_ft8dt_cc_01.RAW D111202_MGH_445_OGE05_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 61 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 10_11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE010_11_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE010_11_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 62 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE06_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE06_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 63 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE07_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE07_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 64 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE08_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE08_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 65 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE09_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE09_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 1 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 1 not pooled NT= Extraction purification;AC=NCIT:C113061 run 66 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE12_rafkt_ft8dt_cc_01.RAW D111205_MGH_445_OGE12_rafkt_ft8dt_cc_01.RAW colon carcinoma +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 67 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE01_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE01_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 68 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE02_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE02_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 69 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE03_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE03_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 70 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE04_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE04_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 71 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE05_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE05_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 72 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE06_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE06_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 73 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE07_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE07_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 74 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE08_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE08_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 75 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE09_10_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE09_10_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 76 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE11_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE11_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available normal 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 77 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE12_rafkt_ft8dt_cc_01.RAW D120204_MGH_2207_OGE12_rafkt_ft8dt_cc_01.RAW normal +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 78 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE01_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE01_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 79 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE02_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE02_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 80 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE03_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE03_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 81 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE04_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE04_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 82 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE05_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE05_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 83 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE06_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE06_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 84 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE07_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE07_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 85 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE08_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE08_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 86 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE09_10_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE09_10_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 87 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE11_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE11_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 88 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE12_rafkt_ft8dt_cc_01.RAW D120205_MGH_2205_OGE12_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 89 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE08_rafkt_ft8dt_cc_01.RAW D120217_MGH_2205A_OGE08_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 90 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE09_10_rafkt_ft8dt_cc_01.RAW D120217_MGH_2205A_OGE09_10_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 91 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE11_rafkt_ft8dt_cc_01.RAW D120217_MGH_2205A_OGE11_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 92 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE12_rafkt_ft8dt_cc_01.RAW D120217_MGH_2205A_OGE12_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 93 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE01_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE01_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 94 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE02_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE02_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 95 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE03_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE03_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 96 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE04_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE04_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 97 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE05_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE05_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 98 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE06_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE06_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 2 2 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 99 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE07_rafkt_ft8dt_cc_01.RAW D120221_MGH_2205A_OGE07_rafkt_ft8dt_cc_01.RAW colon carcinoma +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 100 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE01_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE01_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 101 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE02_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE02_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 102 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE03_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE03_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 103 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE04_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE04_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 104 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE05_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE05_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 105 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE06_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE06_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 106 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE07_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE07_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 107 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE08_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE08_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 108 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE09_10_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE09_10_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 109 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE11_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE11_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 110 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE12_rafkt_ft8dt_cc_01.RAW D120222_MGH_2446_OGE12_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 111 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE01_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE01_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 112 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE02_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE02_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 113 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE03_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE03_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 114 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE04_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE04_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 115 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE05_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE05_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 116 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE06_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE06_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 117 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE07_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE07_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 118 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE08_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE08_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 119 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE09_10_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE09_10_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 120 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE11_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE11_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 2 2 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 2 not pooled NT= Extraction purification;AC=NCIT:C113061 run 121 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE12_rafkt_ft8dt_cc_01.RAW D120223_MGH_2446A_OGE12_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 122 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE03_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE03_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 123 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE04_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE04_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 124 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE05_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE05_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 125 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE06_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE06_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 126 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE07_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE07_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 127 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE08_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE08_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 128 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 129 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE11_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE11_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 130 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE12_rafkt_ft8dt_cc_01.RAW D120417_MGH_HS1_NLi_OGE12_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 131 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120419_MGH_HS1_NLi_OGE01_rafkt_ft8dt_cc_01.RAW D120419_MGH_HS1_NLi_OGE01_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 1] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 132 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120417_LiN_HS1/D120419_MGH_HS1_NLi_OGE02_rafkt_ft8dt_cc_01.RAW D120419_MGH_HS1_NLi_OGE02_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 133 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE01_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE01_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 134 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE02_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE02_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 135 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE03_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE03_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 136 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE04_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE04_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 137 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE05_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE05_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 138 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE06_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE06_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 139 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE07_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE07_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 140 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE08_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE08_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 141 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 142 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE11_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE11_rafkt_ft8dt_cc_01.RAW normal +Normal Liver [Pool 2] 1 homo sapiens liver hepatocyte not available not available not available normal not applicable pooled NT= Extraction purification;AC=NCIT:C113061 run 143 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE12_rafkt_ft8dt_cc_01.RAW D120504_MGH_HS2_NLi_OGE12_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 144 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE01_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE01_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 145 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE02_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE02_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 146 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE03_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE03_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 147 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE04_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE04_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 148 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE05_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE05_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 149 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE06_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE06_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 150 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE07_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE07_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 151 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE08_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE08_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 152 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE09_10_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE09_10_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 153 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE11_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE11_rafkt_ft8dt_cc_01.RAW normal +Normal Colon Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available normal 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 154 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE12_rafkt_ft8dt_cc_01.RAW D121010_MGH_NCo_1948A_OGE12_rafkt_ft8dt_cc_01.RAW normal +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 155 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE01_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE01_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 156 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE02_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE02_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 157 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE03_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE03_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 158 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE04_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE04_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 159 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE05_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE05_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 160 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE06_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE06_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 161 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE07_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE07_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 162 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE08_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE08_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 163 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE09_10_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE09_10_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 164 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE11_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE11_rafkt_ft8dt_cc_01.RAW colon carcinoma +Colon Tumor Patient 3 1 homo sapiens colon colon epithelial cell not available not available not available colon carcinoma 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 165 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE12_rafkt_ft8dt_cc_01.RAW D121011_MGH_CoK_1947_OGE12_rafkt_ft8dt_cc_01.RAW colon carcinoma +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 166 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE01_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE01_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 167 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE02_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE02_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 168 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE03_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE03_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 169 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE04_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE04_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 170 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 5 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE05_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE05_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 171 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 6 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE06_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE06_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 172 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 7 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE07_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE07_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 173 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 8 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE08_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE08_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 174 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 9_10 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE09_10_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE09_10_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 175 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 11 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE11_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE11_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver +Liver Metastasis Patient 3 1 homo sapiens liver hepatocyte not available not available not available metastatic malignant neoplasm in the liver 3 not pooled NT= Extraction purification;AC=NCIT:C113061 run 176 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 off-gel electrophoresis 12 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE12_rafkt_ft8dt_cc_01.RAW D121012_MGH_LiK_2333A_OGE12_rafkt_ft8dt_cc_01.RAW metastatic malignant neoplasm in the liver \ No newline at end of file diff --git a/annotated-projects/MSV000080451/MSV000080451.sdrf.tsv b/annotated-projects/MSV000080451/MSV000080451.sdrf.tsv index f53ba450..8c178343 100644 --- a/annotated-projects/MSV000080451/MSV000080451.sdrf.tsv +++ b/annotated-projects/MSV000080451/MSV000080451.sdrf.tsv @@ -1,72 +1,72 @@ source name characteristics[biological replicate] characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[age] characteristics[ancestry category] characteristics[sex] characteristics[disease] characteristics[individual] characteristics[enrichment process] assay name technology type comment[cleavage agent details] comment[fractionation method] comment[fraction identifier] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[instrument] comment[label] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[tool metadata] comment[file uri] comment[data file] factor value[disease] -Donor_1 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 1 NT= Extraction purification;AC=NCIT:C113061 run 1 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1A.raw 020313ESGNBM1A.raw normal -Donor_1 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 1 NT= Extraction purification;AC=NCIT:C113061 run 2 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1B.raw 020313ESGNBM1B.raw normal -Donor_1 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 1 NT= Extraction purification;AC=NCIT:C113061 run 3 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1C.raw 020313ESGNBM1C.raw normal -Donor_10 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 10 NT= Extraction purification;AC=NCIT:C113061 run 4 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4A.raw 101713ESGNBM4A.raw normal -Donor_10 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 10 NT= Extraction purification;AC=NCIT:C113061 run 5 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4B.raw 101713ESGNBM4B.raw normal -Donor_10 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 10 NT= Extraction purification;AC=NCIT:C113061 run 6 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4C.raw 101713ESGNBM4C.raw normal -Donor_10 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 10 NT= Extraction purification;AC=NCIT:C113061 run 7 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 4 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4D.raw 101713ESGNBM4D.raw normal -Donor_2 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 2 NT= Extraction purification;AC=NCIT:C113061 run 8 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2A.raw 020313ESGNBM2A.raw normal -Donor_2 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 2 NT= Extraction purification;AC=NCIT:C113061 run 9 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2B.raw 020313ESGNBM2B.raw normal -Donor_2 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 2 NT= Extraction purification;AC=NCIT:C113061 run 10 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2C.raw 020313ESGNBM2C.raw normal -Donor_3 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 3 NT= Extraction purification;AC=NCIT:C113061 run 11 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3A.raw 020313ESGNBM3A.raw normal -Donor_3 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 3 NT= Extraction purification;AC=NCIT:C113061 run 12 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3B.raw 020313ESGNBM3B.raw normal -Donor_3 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 3 NT= Extraction purification;AC=NCIT:C113061 run 13 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3C.raw 020313ESGNBM3C.raw normal -Donor_4 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 4 NT= Extraction purification;AC=NCIT:C113061 run 14 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_4/042213RSGNBM3A.raw 042213RSGNBM3A.raw normal -Donor_4 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 4 NT= Extraction purification;AC=NCIT:C113061 run 15 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_4/042213RSGNBM3B.raw 042213RSGNBM3B.raw normal -Donor_5 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 5 NT= Extraction purification;AC=NCIT:C113061 run 16 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_5/042213RSGNBM4ARe.raw 042213RSGNBM4ARe.raw normal -Donor_5 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 5 NT= Extraction purification;AC=NCIT:C113061 run 17 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_5/042213RSGNBM4B.raw 042213RSGNBM4B.raw normal -Donor_6 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 6 NT= Extraction purification;AC=NCIT:C113061 run 18 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_6/042213RSGNBM5A.raw 042213RSGNBM5A.raw normal -Donor_6 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 6 NT= Extraction purification;AC=NCIT:C113061 run 19 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_6/042213RSGNBM5B.raw 042213RSGNBM5B.raw normal -Donor_7 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 7 NT= Extraction purification;AC=NCIT:C113061 run 20 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1A.raw 101713ESGNBM1A.raw normal -Donor_7 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 7 NT= Extraction purification;AC=NCIT:C113061 run 21 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1B.raw 101713ESGNBM1B.raw normal -Donor_7 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 7 NT= Extraction purification;AC=NCIT:C113061 run 22 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1C.raw 101713ESGNBM1C.raw normal -Donor_8 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 8 NT= Extraction purification;AC=NCIT:C113061 run 23 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2A.raw 101713ESGNBM2A.raw normal -Donor_8 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 8 NT= Extraction purification;AC=NCIT:C113061 run 24 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2B.raw 101713ESGNBM2B.raw normal -Donor_8 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 8 NT= Extraction purification;AC=NCIT:C113061 run 25 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2C.raw 101713ESGNBM2C.raw normal -Donor_8 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 8 NT= Extraction purification;AC=NCIT:C113061 run 26 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 4 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2D.raw 101713ESGNBM2D.raw normal -Donor_9 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 9 NT= Extraction purification;AC=NCIT:C113061 run 27 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3A.raw 101713ESGNBM3A.raw normal -Donor_9 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 9 NT= Extraction purification;AC=NCIT:C113061 run 28 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3B.raw 101713ESGNBM3B.raw normal -Donor_9 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 9 NT= Extraction purification;AC=NCIT:C113061 run 29 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3C.raw 101713ESGNBM3C.raw normal -MGUS_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 11 NT= Extraction purification;AC=NCIT:C113061 run 30 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12A.raw 102913ESGTO12A.raw monoclonal gammopathy -MGUS_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 11 NT= Extraction purification;AC=NCIT:C113061 run 31 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12B.raw 102913ESGTO12B.raw monoclonal gammopathy -MGUS_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 11 NT= Extraction purification;AC=NCIT:C113061 run 32 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12C.raw 102913ESGTO12C.raw monoclonal gammopathy -MGUS_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 12 NT= Extraction purification;AC=NCIT:C113061 run 33 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17A.raw 102913ESGTO17A.raw monoclonal gammopathy -MGUS_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 12 NT= Extraction purification;AC=NCIT:C113061 run 34 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17B.raw 102913ESGTO17B.raw monoclonal gammopathy -MGUS_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 12 NT= Extraction purification;AC=NCIT:C113061 run 35 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17C.raw 102913ESGTO17C.raw monoclonal gammopathy -MGUS_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 13 NT= Extraction purification;AC=NCIT:C113061 run 36 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20A.raw 102913ESGTO20A.raw monoclonal gammopathy -MGUS_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 13 NT= Extraction purification;AC=NCIT:C113061 run 37 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20B.raw 102913ESGTO20B.raw monoclonal gammopathy -MGUS_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 13 NT= Extraction purification;AC=NCIT:C113061 run 38 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20B_1.raw 102913ESGTO20B_1.raw monoclonal gammopathy -New_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 14 NT= Extraction purification;AC=NCIT:C113061 run 39 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13A.raw 102913ESGTO13A.raw multiple myeloma -New_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 14 NT= Extraction purification;AC=NCIT:C113061 run 40 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13B.raw 102913ESGTO13B.raw multiple myeloma -New_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 14 NT= Extraction purification;AC=NCIT:C113061 run 41 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13C.raw 102913ESGTO13C.raw multiple myeloma -New_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 15 NT= Extraction purification;AC=NCIT:C113061 run 42 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_2/102913ESGTO15A.raw 102913ESGTO15A.raw multiple myeloma -New_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 15 NT= Extraction purification;AC=NCIT:C113061 run 43 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_2/102913ESGTO15B.raw 102913ESGTO15B.raw multiple myeloma -New_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 16 NT= Extraction purification;AC=NCIT:C113061 run 44 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16A.raw 102913ESGTO16A.raw multiple myeloma -New_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 16 NT= Extraction purification;AC=NCIT:C113061 run 45 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16B.raw 102913ESGTO16B.raw multiple myeloma -New_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 16 NT= Extraction purification;AC=NCIT:C113061 run 46 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16C.raw 102913ESGTO16C.raw multiple myeloma -New_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 17 NT= Extraction purification;AC=NCIT:C113061 run 47 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1A.raw 020313ESGMM1A.raw multiple myeloma -New_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 17 NT= Extraction purification;AC=NCIT:C113061 run 48 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1B.raw 020313ESGMM1B.raw multiple myeloma -New_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 17 NT= Extraction purification;AC=NCIT:C113061 run 49 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1C.raw 020313ESGMM1C.raw multiple myeloma -New_Patient_5 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 18 NT= Extraction purification;AC=NCIT:C113061 run 50 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2A.raw 020313ESGMM2A.raw multiple myeloma -New_Patient_5 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 18 NT= Extraction purification;AC=NCIT:C113061 run 51 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2B.raw 020313ESGMM2B.raw multiple myeloma -New_Patient_5 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 18 NT= Extraction purification;AC=NCIT:C113061 run 52 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2C.raw 020313ESGMM2C.raw multiple myeloma -New_Patient_6 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 19 NT= Extraction purification;AC=NCIT:C113061 run 53 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_6/042213RSGMM6A.raw 042213RSGMM6A.raw multiple myeloma -New_Patient_6 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 19 NT= Extraction purification;AC=NCIT:C113061 run 54 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_6/042213RSGMM6B.raw 042213RSGMM6B.raw multiple myeloma -New_Patient_7 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 20 NT= Extraction purification;AC=NCIT:C113061 run 55 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_7/042213RSGMM9A.raw 042213RSGMM9A.raw multiple myeloma -New_Patient_7 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 20 NT= Extraction purification;AC=NCIT:C113061 run 56 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_7/042213RSGMM9B.raw 042213RSGMM9B.raw multiple myeloma -Relapsed_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 21 NT= Extraction purification;AC=NCIT:C113061 run 57 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11A.raw 102913ESGTO11A.raw multiple myeloma -Relapsed_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 21 NT= Extraction purification;AC=NCIT:C113061 run 58 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11B.raw 102913ESGTO11B.raw multiple myeloma -Relapsed_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 21 NT= Extraction purification;AC=NCIT:C113061 run 59 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11C.raw 102913ESGTO11C.raw multiple myeloma -Relapsed_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 21 NT= Extraction purification;AC=NCIT:C113061 run 60 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 4 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11D.raw 102913ESGTO11D.raw multiple myeloma -Relapsed_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 22 NT= Extraction purification;AC=NCIT:C113061 run 61 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14A.raw 102913ESGTO14A.raw multiple myeloma -Relapsed_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 22 NT= Extraction purification;AC=NCIT:C113061 run 62 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14B.raw 102913ESGTO14B.raw multiple myeloma -Relapsed_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 22 NT= Extraction purification;AC=NCIT:C113061 run 63 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14C.raw 102913ESGTO14C.raw multiple myeloma -Relapsed_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 23 NT= Extraction purification;AC=NCIT:C113061 run 64 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_3/102913ESGTO19A.raw 102913ESGTO19A.raw multiple myeloma -Relapsed_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 23 NT= Extraction purification;AC=NCIT:C113061 run 65 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_3/102913ESGTO19B.raw 102913ESGTO19B.raw multiple myeloma -Relapsed_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 24 NT= Extraction purification;AC=NCIT:C113061 run 66 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3A.raw 020313ESGMM3A.raw multiple myeloma -Relapsed_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 24 NT= Extraction purification;AC=NCIT:C113061 run 67 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3B.raw 020313ESGMM3B.raw multiple myeloma -Relapsed_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 24 NT= Extraction purification;AC=NCIT:C113061 run 68 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3C.raw 020313ESGMM3C.raw multiple myeloma -Relapsed_Patient_5 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 25 NT= Extraction purification;AC=NCIT:C113061 run 69 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_5/042213RSGMM7A.raw 042213RSGMM7A.raw multiple myeloma -Relapsed_Patient_5 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 25 NT= Extraction purification;AC=NCIT:C113061 run 70 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_5/042213RSGMM7B.raw 042213RSGMM7B.raw multiple myeloma -Relapsed_Patient_6 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 26 NT= Extraction purification;AC=NCIT:C113061 run 71 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_6/042213RSGMM8A.raw 042213RSGMM8A.raw multiple myeloma \ No newline at end of file +Donor_1 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 1 NT= Extraction purification;AC=NCIT:C113061 run 1 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1A.raw 020313ESGNBM1A.raw normal +Donor_1 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 1 NT= Extraction purification;AC=NCIT:C113061 run 2 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1B.raw 020313ESGNBM1B.raw normal +Donor_1 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 1 NT= Extraction purification;AC=NCIT:C113061 run 3 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1C.raw 020313ESGNBM1C.raw normal +Donor_10 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 10 NT= Extraction purification;AC=NCIT:C113061 run 4 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4A.raw 101713ESGNBM4A.raw normal +Donor_10 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 10 NT= Extraction purification;AC=NCIT:C113061 run 5 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4B.raw 101713ESGNBM4B.raw normal +Donor_10 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 10 NT= Extraction purification;AC=NCIT:C113061 run 6 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4C.raw 101713ESGNBM4C.raw normal +Donor_10 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 10 NT= Extraction purification;AC=NCIT:C113061 run 7 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4D.raw 101713ESGNBM4D.raw normal +Donor_2 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 2 NT= Extraction purification;AC=NCIT:C113061 run 8 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2A.raw 020313ESGNBM2A.raw normal +Donor_2 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 2 NT= Extraction purification;AC=NCIT:C113061 run 9 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2B.raw 020313ESGNBM2B.raw normal +Donor_2 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 2 NT= Extraction purification;AC=NCIT:C113061 run 10 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2C.raw 020313ESGNBM2C.raw normal +Donor_3 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 3 NT= Extraction purification;AC=NCIT:C113061 run 11 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3A.raw 020313ESGNBM3A.raw normal +Donor_3 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 3 NT= Extraction purification;AC=NCIT:C113061 run 12 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3B.raw 020313ESGNBM3B.raw normal +Donor_3 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 3 NT= Extraction purification;AC=NCIT:C113061 run 13 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3C.raw 020313ESGNBM3C.raw normal +Donor_4 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 4 NT= Extraction purification;AC=NCIT:C113061 run 14 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_4/042213RSGNBM3A.raw 042213RSGNBM3A.raw normal +Donor_4 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 4 NT= Extraction purification;AC=NCIT:C113061 run 15 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_4/042213RSGNBM3B.raw 042213RSGNBM3B.raw normal +Donor_5 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 5 NT= Extraction purification;AC=NCIT:C113061 run 16 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_5/042213RSGNBM4ARe.raw 042213RSGNBM4ARe.raw normal +Donor_5 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 5 NT= Extraction purification;AC=NCIT:C113061 run 17 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_5/042213RSGNBM4B.raw 042213RSGNBM4B.raw normal +Donor_6 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 6 NT= Extraction purification;AC=NCIT:C113061 run 18 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_6/042213RSGNBM5A.raw 042213RSGNBM5A.raw normal +Donor_6 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 6 NT= Extraction purification;AC=NCIT:C113061 run 19 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_6/042213RSGNBM5B.raw 042213RSGNBM5B.raw normal +Donor_7 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 7 NT= Extraction purification;AC=NCIT:C113061 run 20 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1A.raw 101713ESGNBM1A.raw normal +Donor_7 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 7 NT= Extraction purification;AC=NCIT:C113061 run 21 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1B.raw 101713ESGNBM1B.raw normal +Donor_7 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 7 NT= Extraction purification;AC=NCIT:C113061 run 22 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1C.raw 101713ESGNBM1C.raw normal +Donor_8 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 8 NT= Extraction purification;AC=NCIT:C113061 run 23 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2A.raw 101713ESGNBM2A.raw normal +Donor_8 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 8 NT= Extraction purification;AC=NCIT:C113061 run 24 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2B.raw 101713ESGNBM2B.raw normal +Donor_8 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 8 NT= Extraction purification;AC=NCIT:C113061 run 25 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2C.raw 101713ESGNBM2C.raw normal +Donor_8 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 8 NT= Extraction purification;AC=NCIT:C113061 run 26 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2D.raw 101713ESGNBM2D.raw normal +Donor_9 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 9 NT= Extraction purification;AC=NCIT:C113061 run 27 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3A.raw 101713ESGNBM3A.raw normal +Donor_9 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 9 NT= Extraction purification;AC=NCIT:C113061 run 28 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3B.raw 101713ESGNBM3B.raw normal +Donor_9 1 homo sapiens bone marrow bone marrow cell not available not available not available normal 9 NT= Extraction purification;AC=NCIT:C113061 run 29 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3C.raw 101713ESGNBM3C.raw normal +MGUS_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 11 NT= Extraction purification;AC=NCIT:C113061 run 30 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12A.raw 102913ESGTO12A.raw monoclonal gammopathy +MGUS_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 11 NT= Extraction purification;AC=NCIT:C113061 run 31 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12B.raw 102913ESGTO12B.raw monoclonal gammopathy +MGUS_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 11 NT= Extraction purification;AC=NCIT:C113061 run 32 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12C.raw 102913ESGTO12C.raw monoclonal gammopathy +MGUS_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 12 NT= Extraction purification;AC=NCIT:C113061 run 33 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17A.raw 102913ESGTO17A.raw monoclonal gammopathy +MGUS_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 12 NT= Extraction purification;AC=NCIT:C113061 run 34 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17B.raw 102913ESGTO17B.raw monoclonal gammopathy +MGUS_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 12 NT= Extraction purification;AC=NCIT:C113061 run 35 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17C.raw 102913ESGTO17C.raw monoclonal gammopathy +MGUS_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 13 NT= Extraction purification;AC=NCIT:C113061 run 36 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20A.raw 102913ESGTO20A.raw monoclonal gammopathy +MGUS_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 13 NT= Extraction purification;AC=NCIT:C113061 run 37 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20B.raw 102913ESGTO20B.raw monoclonal gammopathy +MGUS_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available monoclonal gammopathy 13 NT= Extraction purification;AC=NCIT:C113061 run 38 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20B_1.raw 102913ESGTO20B_1.raw monoclonal gammopathy +New_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 14 NT= Extraction purification;AC=NCIT:C113061 run 39 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13A.raw 102913ESGTO13A.raw multiple myeloma +New_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 14 NT= Extraction purification;AC=NCIT:C113061 run 40 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13B.raw 102913ESGTO13B.raw multiple myeloma +New_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 14 NT= Extraction purification;AC=NCIT:C113061 run 41 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13C.raw 102913ESGTO13C.raw multiple myeloma +New_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 15 NT= Extraction purification;AC=NCIT:C113061 run 42 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_2/102913ESGTO15A.raw 102913ESGTO15A.raw multiple myeloma +New_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 15 NT= Extraction purification;AC=NCIT:C113061 run 43 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_2/102913ESGTO15B.raw 102913ESGTO15B.raw multiple myeloma +New_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 16 NT= Extraction purification;AC=NCIT:C113061 run 44 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16A.raw 102913ESGTO16A.raw multiple myeloma +New_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 16 NT= Extraction purification;AC=NCIT:C113061 run 45 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16B.raw 102913ESGTO16B.raw multiple myeloma +New_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 16 NT= Extraction purification;AC=NCIT:C113061 run 46 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16C.raw 102913ESGTO16C.raw multiple myeloma +New_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 17 NT= Extraction purification;AC=NCIT:C113061 run 47 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1A.raw 020313ESGMM1A.raw multiple myeloma +New_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 17 NT= Extraction purification;AC=NCIT:C113061 run 48 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1B.raw 020313ESGMM1B.raw multiple myeloma +New_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 17 NT= Extraction purification;AC=NCIT:C113061 run 49 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1C.raw 020313ESGMM1C.raw multiple myeloma +New_Patient_5 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 18 NT= Extraction purification;AC=NCIT:C113061 run 50 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2A.raw 020313ESGMM2A.raw multiple myeloma +New_Patient_5 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 18 NT= Extraction purification;AC=NCIT:C113061 run 51 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2B.raw 020313ESGMM2B.raw multiple myeloma +New_Patient_5 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 18 NT= Extraction purification;AC=NCIT:C113061 run 52 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2C.raw 020313ESGMM2C.raw multiple myeloma +New_Patient_6 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 19 NT= Extraction purification;AC=NCIT:C113061 run 53 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_6/042213RSGMM6A.raw 042213RSGMM6A.raw multiple myeloma +New_Patient_6 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 19 NT= Extraction purification;AC=NCIT:C113061 run 54 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_6/042213RSGMM6B.raw 042213RSGMM6B.raw multiple myeloma +New_Patient_7 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 20 NT= Extraction purification;AC=NCIT:C113061 run 55 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_7/042213RSGMM9A.raw 042213RSGMM9A.raw multiple myeloma +New_Patient_7 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 20 NT= Extraction purification;AC=NCIT:C113061 run 56 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/New_Patient_7/042213RSGMM9B.raw 042213RSGMM9B.raw multiple myeloma +Relapsed_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 21 NT= Extraction purification;AC=NCIT:C113061 run 57 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11A.raw 102913ESGTO11A.raw multiple myeloma +Relapsed_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 21 NT= Extraction purification;AC=NCIT:C113061 run 58 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11B.raw 102913ESGTO11B.raw multiple myeloma +Relapsed_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 21 NT= Extraction purification;AC=NCIT:C113061 run 59 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11C.raw 102913ESGTO11C.raw multiple myeloma +Relapsed_Patient_1 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 21 NT= Extraction purification;AC=NCIT:C113061 run 60 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 4 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11D.raw 102913ESGTO11D.raw multiple myeloma +Relapsed_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 22 NT= Extraction purification;AC=NCIT:C113061 run 61 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14A.raw 102913ESGTO14A.raw multiple myeloma +Relapsed_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 22 NT= Extraction purification;AC=NCIT:C113061 run 62 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14B.raw 102913ESGTO14B.raw multiple myeloma +Relapsed_Patient_2 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 22 NT= Extraction purification;AC=NCIT:C113061 run 63 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14C.raw 102913ESGTO14C.raw multiple myeloma +Relapsed_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 23 NT= Extraction purification;AC=NCIT:C113061 run 64 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_3/102913ESGTO19A.raw 102913ESGTO19A.raw multiple myeloma +Relapsed_Patient_3 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 23 NT= Extraction purification;AC=NCIT:C113061 run 65 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_3/102913ESGTO19B.raw 102913ESGTO19B.raw multiple myeloma +Relapsed_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 24 NT= Extraction purification;AC=NCIT:C113061 run 66 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3A.raw 020313ESGMM3A.raw multiple myeloma +Relapsed_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 24 NT= Extraction purification;AC=NCIT:C113061 run 67 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3B.raw 020313ESGMM3B.raw multiple myeloma +Relapsed_Patient_4 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 24 NT= Extraction purification;AC=NCIT:C113061 run 68 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 3 0.7 Da 20 ppm 1 NT=LTQ Orbitrap Elite;AC=MS:1001910 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3C.raw 020313ESGMM3C.raw multiple myeloma +Relapsed_Patient_5 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 25 NT= Extraction purification;AC=NCIT:C113061 run 69 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_5/042213RSGMM7A.raw 042213RSGMM7A.raw multiple myeloma +Relapsed_Patient_5 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 25 NT= Extraction purification;AC=NCIT:C113061 run 70 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 2 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_5/042213RSGMM7B.raw 042213RSGMM7B.raw multiple myeloma +Relapsed_Patient_6 1 homo sapiens bone marrow bone marrow cell not available not available not available multiple myeloma 26 NT= Extraction purification;AC=NCIT:C113061 run 71 proteomic profiling by mass spectrometry NT=Trypsin;AC=MS:1001251 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 1 0.7 Da 20 ppm 1 NT=LTQ Orbitrap XL;AC=MS:1000556 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P lesSDRF v0.1.0 f.MSV000080451/raw/RawData/Relapsed_Patient_6/042213RSGMM8A.raw 042213RSGMM8A.raw multiple myeloma \ No newline at end of file diff --git a/annotated-projects/PXD003469/PXD003469.sdrf.tsv b/annotated-projects/PXD003469/PXD003469.sdrf.tsv index d1ea2e19..12fe6cd8 100644 --- a/annotated-projects/PXD003469/PXD003469.sdrf.tsv +++ b/annotated-projects/PXD003469/PXD003469.sdrf.tsv @@ -242,15 +242,15 @@ Sample 80 Homo sapiens lymph node not available not available Anaplastic large c Sample 81 Homo sapiens lymphoblastic not available not available Anaplastic large cell lymphoma not available T lymphocyte Mac-1 no compound glycosylation 2 cell run 241 proteomic profiling by mass spectrometry UM_A_2012_0818_a1-MAC1.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a1-MAC1.mzXML 1 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Mac-1 no compound Sample 81 Homo sapiens lymphoblastic not available not available Anaplastic large cell lymphoma not available T lymphocyte Mac-1 no compound glycosylation 2 cell run 242 proteomic profiling by mass spectrometry UM_A_2012_0818_a2-MAC1.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a2-MAC1.mzXML 2 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Mac-1 no compound Sample 81 Homo sapiens lymphoblastic not available not available Anaplastic large cell lymphoma not available T lymphocyte Mac-1 no compound glycosylation 2 cell run 243 proteomic profiling by mass spectrometry UM_A_2012_0818_a3-MAC1.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a3-MAC1.mzXML 3 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Mac-1 no compound -Sample 82 Homo sapiens lymphoblastic not available male acute T cell leukemia T lymphocyte Jurkat no compound glycosylation 1 cell run 244 proteomic profiling by mass spectrometry UM_A_2012_0863_a1-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a1-JURKAT.mzXML 1 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound -Sample 82 Homo sapiens lymphoblastic not available male acute T cell leukemia T lymphocyte Jurkat no compound glycosylation 1 cell run 245 proteomic profiling by mass spectrometry UM_A_2012_0863_a2-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a2-JURKAT.mzXML 2 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound -Sample 82 Homo sapiens lymphoblastic not available male acute T cell leukemia T lymphocyte Jurkat no compound glycosylation 1 cell run 246 proteomic profiling by mass spectrometry UM_A_2012_0863_a3-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a3-JURKAT.mzXML 3 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound -Sample 83 Homo sapiens lymphoblastic not available male acute T cell leukemia T lymphocyte Jurkat no compound glycosylation 2 cell run 247 proteomic profiling by mass spectrometry UM_A_2012_0864_a1-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a1-JURKAT.mzXML 1 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound -Sample 83 Homo sapiens lymphoblastic not available male acute T cell leukemia T lymphocyte Jurkat no compound glycosylation 2 cell run 248 proteomic profiling by mass spectrometry UM_A_2012_0864_a2-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a2-JURKAT.mzXML 2 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound -Sample 83 Homo sapiens lymphoblastic not available male acute T cell leukemia T lymphocyte Jurkat no compound glycosylation 2 cell run 249 proteomic profiling by mass spectrometry UM_A_2012_0864_a3-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a3-JURKAT.mzXML 3 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound -Sample 84 Homo sapiens lymphoblastic not available male acute T cell leukemia T lymphocyte Jurkat no compound glycosylation 3 cell run 250 proteomic profiling by mass spectrometry UM_A_2012_0866_a1-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a1-JURKAT.mzXML 1 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound -Sample 84 Homo sapiens lymphoblastic not available male acute T cell leukemia T lymphocyte Jurkat no compound glycosylation 3 cell run 251 proteomic profiling by mass spectrometry UM_A_2012_0866_a2-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a2-JURKAT.mzXML 2 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound -Sample 84 Homo sapiens lymphoblastic not available male acute T cell leukemia T lymphocyte Jurkat no compound glycosylation 3 cell run 252 proteomic profiling by mass spectrometry UM_A_2012_0866_a3-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a3-JURKAT.mzXML 3 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound +Sample 82 Homo sapiens lymphoblastic not available male acute T cell leukemia not available T lymphocyte Jurkat no compound glycosylation 1 cell run 244 proteomic profiling by mass spectrometry UM_A_2012_0863_a1-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a1-JURKAT.mzXML 1 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound +Sample 82 Homo sapiens lymphoblastic not available male acute T cell leukemia not available T lymphocyte Jurkat no compound glycosylation 1 cell run 245 proteomic profiling by mass spectrometry UM_A_2012_0863_a2-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a2-JURKAT.mzXML 2 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound +Sample 82 Homo sapiens lymphoblastic not available male acute T cell leukemia not available T lymphocyte Jurkat no compound glycosylation 1 cell run 246 proteomic profiling by mass spectrometry UM_A_2012_0863_a3-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a3-JURKAT.mzXML 3 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound +Sample 83 Homo sapiens lymphoblastic not available male acute T cell leukemia not available T lymphocyte Jurkat no compound glycosylation 2 cell run 247 proteomic profiling by mass spectrometry UM_A_2012_0864_a1-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a1-JURKAT.mzXML 1 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound +Sample 83 Homo sapiens lymphoblastic not available male acute T cell leukemia not available T lymphocyte Jurkat no compound glycosylation 2 cell run 248 proteomic profiling by mass spectrometry UM_A_2012_0864_a2-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a2-JURKAT.mzXML 2 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound +Sample 83 Homo sapiens lymphoblastic not available male acute T cell leukemia not available T lymphocyte Jurkat no compound glycosylation 2 cell run 249 proteomic profiling by mass spectrometry UM_A_2012_0864_a3-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a3-JURKAT.mzXML 3 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound +Sample 84 Homo sapiens lymphoblastic not available male acute T cell leukemia not available T lymphocyte Jurkat no compound glycosylation 3 cell run 250 proteomic profiling by mass spectrometry UM_A_2012_0866_a1-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a1-JURKAT.mzXML 1 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound +Sample 84 Homo sapiens lymphoblastic not available male acute T cell leukemia not available T lymphocyte Jurkat no compound glycosylation 3 cell run 251 proteomic profiling by mass spectrometry UM_A_2012_0866_a2-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a2-JURKAT.mzXML 2 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound +Sample 84 Homo sapiens lymphoblastic not available male acute T cell leukemia not available T lymphocyte Jurkat no compound glycosylation 3 cell run 252 proteomic profiling by mass spectrometry UM_A_2012_0866_a3-JURKAT.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a3-JURKAT.mzXML 3 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da Jurkat no compound Sample 85 Homo sapiens peripheral blood 75Y female Mantle cell lymphoma not applicable not applicable not applicable no compound glycosylation 1 cell run 253 proteomic profiling by mass spectrometry UM_A_2012_0916_a1-PATEINT_3.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a1-PATEINT_3.mzXML 1 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da not applicable no compound Sample 85 Homo sapiens peripheral blood 75Y female Mantle cell lymphoma not applicable not applicable not applicable no compound glycosylation 1 cell run 254 proteomic profiling by mass spectrometry UM_A_2012_0916_a2-PATEINT_3.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a2-PATEINT_3.mzXML 2 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da not applicable no compound Sample 85 Homo sapiens peripheral blood 75Y female Mantle cell lymphoma not applicable not applicable not applicable no compound glycosylation 1 cell run 255 proteomic profiling by mass spectrometry UM_A_2012_0916_a3-PATEINT_3.mzXML https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a3-PATEINT_3.mzXML 3 1 AC=MS:1002038;NT=label free sample NT=Trypsin;AC=MS:1001251 NT=LTQ Orbitrap XL;AC=MS:1000556 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4 NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N NT=collision-induced dissociation;AC=MS:1000133 35% NCE 50 ppm 0.8 Da not applicable no compound diff --git a/annotated-projects/PXD012307/PXD012307.sdrf.tsv b/annotated-projects/PXD012307/PXD012307.sdrf.tsv index 88439c91..b99d8814 100644 --- a/annotated-projects/PXD012307/PXD012307.sdrf.tsv +++ b/annotated-projects/PXD012307/PXD012307.sdrf.tsv @@ -1,4 +1,4 @@ -source name characteristics[organism] characteristics[organism part] characteristics[cell type] comment[age] characteristics[ancestry category] characteristics[sex] characteristics[disease] characteristics[biological replicate] assay name comment[proteomexchange accession number] comment[data file] comment[file uri] comment[fraction identifier] characteristics[technical replicate] comment[instrument] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[cleavage agent details] comment[label] comment[precursor mass tolerance] comment[fragment mass tolerance] +source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[age] characteristics[ancestry category] characteristics[sex] characteristics[disease] characteristics[biological replicate] assay name comment[proteomexchange accession number] comment[data file] comment[file uri] comment[fraction identifier] comment[technical replicate] comment[instrument] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[cleavage agent details] comment[label] comment[precursor mass tolerance] comment[fragment mass tolerance] Sample 1 mus musculus Lungs not applicable 24 months not applicable not available not available 1 run 1 PXD012307 20131023_EXQ8_HeSc_SA_ECM_old_14_1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/01/PXD012307/20131023_EXQ8_HeSc_SA_ECM_old_14_1.raw 1 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Oxidation;MT=Variable;TA=P;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin AC=MS:1001309;NT=Lys-C label free 4.5 ppm 20 ppm Sample 1 mus musculus Lungs not applicable 24 months not applicable not available not available 1 run 2 PXD012307 20131023_EXQ8_HeSc_SA_ECM_old_14_2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/01/PXD012307/20131023_EXQ8_HeSc_SA_ECM_old_14_2.raw 2 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Oxidation;MT=Variable;TA=P;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin AC=MS:1001309;NT=Lys-C label free 4.5 ppm 20 ppm Sample 1 mus musculus Lungs not applicable 24 months not applicable not available not available 1 run 3 PXD012307 20131023_EXQ8_HeSc_SA_ECM_old_14_3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/01/PXD012307/20131023_EXQ8_HeSc_SA_ECM_old_14_3.raw 3 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Oxidation;MT=Variable;TA=P;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin AC=MS:1001309;NT=Lys-C label free 4.5 ppm 20 ppm diff --git a/annotated-projects/PXD014557/PXD014557.sdrf.tsv b/annotated-projects/PXD014557/PXD014557.sdrf.tsv index 55f812cd..61029832 100644 --- a/annotated-projects/PXD014557/PXD014557.sdrf.tsv +++ b/annotated-projects/PXD014557/PXD014557.sdrf.tsv @@ -1,401 +1,401 @@ -source name characteristics[organism] characteristics[organism part] characteristics[organism part] characteristics[cell type] characteristics[age] characteristics[ancestry category] characteristics[sex] characteristics[disease] characteristics[developmental stage] characteristics[biological replicate] comment[Amyloid stage] characteristics[individual] assay name technology type comment[proteomexchange accession number] comment[data file] comment[file uri] comment[fraction identifier] comment[instrument] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[label] comment[PTM] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[BRAAK] comment[Age at Death] factor value[sex] factor value[disease] -Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 1 run 1 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 1 run 2 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 1 run 3 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 1 run 4 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 1 run 5 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 1 run 6 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 1 run 7 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 1 run 8 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 1 run 9 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 1 run 10 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 2 run 11 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 2 run 12 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 2 run 13 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 2 run 14 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 2 run 15 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 2 run 16 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 2 run 17 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 2 run 18 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 2 run 19 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 2 run 20 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 3 run 21 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 3 run 22 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 3 run 23 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 3 run 24 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 3 run 25 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 3 run 26 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 3 run 27 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 3 run 28 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 3 run 29 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 3 run 30 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 4 run 31 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 4 run 32 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 4 run 33 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 4 run 34 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 4 run 35 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 4 run 36 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 4 run 37 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 4 run 38 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 4 run 39 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 4 run 40 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 5 run 41 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 5 run 42 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 5 run 43 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 5 run 44 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 5 run 45 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 5 run 46 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 5 run 47 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 5 run 48 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 5 run 49 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 5 run 50 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 6 run 51 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 6 run 52 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 6 run 53 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 6 run 54 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 6 run 55 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 6 run 56 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 6 run 57 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 6 run 58 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 6 run 59 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 6 run 60 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 7 run 61 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 7 run 62 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 7 run 63 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 7 run 64 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 7 run 65 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 7 run 66 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 7 run 67 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 7 run 68 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 7 run 69 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 7 run 70 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 8 run 71 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 8 run 72 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 8 run 73 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 8 run 74 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 8 run 75 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 8 run 76 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 8 run 77 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 8 run 78 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 8 run 79 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 8 run 80 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 9 run 81 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 9 run 82 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 9 run 83 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 9 run 84 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 9 run 85 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 9 run 86 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 9 run 87 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 9 run 88 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 9 run 89 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 9 run 90 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 10 run 91 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 10 run 92 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 10 run 93 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 10 run 94 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 10 run 95 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 10 run 96 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 10 run 97 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 10 run 98 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 10 run 99 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 10 run 100 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 11 run 101 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 11 run 102 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 11 run 103 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 11 run 104 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 11 run 105 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 11 run 106 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 11 run 107 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 11 run 108 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 11 run 109 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 11 run 110 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 12 run 111 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 12 run 112 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 12 run 113 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 12 run 114 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 12 run 115 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 12 run 116 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 12 run 117 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 12 run 118 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 12 run 119 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 12 run 120 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 13 run 121 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 13 run 122 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 13 run 123 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 13 run 124 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 13 run 125 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 13 run 126 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 13 run 127 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 13 run 128 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 13 run 129 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 13 run 130 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 14 run 131 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 14 run 132 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 14 run 133 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 14 run 134 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 14 run 135 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 14 run 136 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 14 run 137 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 14 run 138 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 14 run 139 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 14 run 140 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 15 run 141 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 15 run 142 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 15 run 143 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 15 run 144 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 15 run 145 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 15 run 146 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 15 run 147 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 15 run 148 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 15 run 149 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 15 run 150 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 16 run 151 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 16 run 152 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 16 run 153 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 16 run 154 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 16 run 155 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 16 run 156 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 16 run 157 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 16 run 158 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 16 run 159 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 16 run 160 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 17 run 161 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 17 run 162 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 17 run 163 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 17 run 164 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 17 run 165 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 17 run 166 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 17 run 167 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 17 run 168 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 17 run 169 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 17 run 170 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 18 run 171 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 18 run 172 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 18 run 173 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 18 run 174 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 18 run 175 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 18 run 176 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 18 run 177 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 18 run 178 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 18 run 179 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 18 run 180 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 19 run 181 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 19 run 182 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 19 run 183 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 19 run 184 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 19 run 185 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 19 run 186 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 19 run 187 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 19 run 188 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 19 run 189 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 19 run 190 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 20 run 191 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 20 run 192 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 20 run 193 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 20 run 194 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 20 run 195 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 20 run 196 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 20 run 197 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 20 run 198 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 20 run 199 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 20 run 200 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 21 run 201 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 21 run 202 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 21 run 203 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 21 run 204 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 21 run 205 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 21 run 206 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 21 run 207 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 21 run 208 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 21 run 209 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 21 run 210 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 22 run 211 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 22 run 212 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 22 run 213 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 22 run 214 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 22 run 215 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 22 run 216 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 22 run 217 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 22 run 218 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 22 run 219 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 22 run 220 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 23 run 221 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 23 run 222 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 23 run 223 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 23 run 224 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 23 run 225 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 23 run 226 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 23 run 227 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 23 run 228 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 23 run 229 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 23 run 230 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 24 run 231 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 24 run 232 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 24 run 233 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 24 run 234 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 24 run 235 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 24 run 236 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 24 run 237 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 24 run 238 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 24 run 239 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 24 run 240 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 25 run 241 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 25 run 242 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 25 run 243 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 25 run 244 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 25 run 245 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 25 run 246 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 25 run 247 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 25 run 248 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 25 run 249 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 25 run 250 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 26 run 251 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 26 run 252 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 26 run 253 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 26 run 254 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 26 run 255 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 26 run 256 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 26 run 257 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 26 run 258 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 26 run 259 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 26 run 260 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 27 run 261 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 27 run 262 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 27 run 263 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 27 run 264 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 27 run 265 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 27 run 266 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 27 run 267 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 27 run 268 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 27 run 269 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 27 run 270 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 28 run 271 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 28 run 272 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 28 run 273 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 28 run 274 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 28 run 275 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 28 run 276 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 28 run 277 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 28 run 278 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 28 run 279 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 28 run 280 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 29 run 281 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 29 run 282 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 29 run 283 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 29 run 284 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 29 run 285 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 29 run 286 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 29 run 287 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 29 run 288 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 29 run 289 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 29 run 290 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 30 run 291 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 30 run 292 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 30 run 293 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 30 run 294 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 30 run 295 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 30 run 296 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 30 run 297 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 30 run 298 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 30 run 299 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 30 run 300 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 31 run 301 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 31 run 302 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 31 run 303 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 31 run 304 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 31 run 305 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 31 run 306 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 31 run 307 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 31 run 308 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 31 run 309 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 31 run 310 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 32 run 311 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 32 run 312 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 32 run 313 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 32 run 314 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 32 run 315 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 32 run 316 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 32 run 317 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 32 run 318 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 32 run 319 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 32 run 320 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 33 run 321 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 33 run 322 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 33 run 323 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 33 run 324 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 33 run 325 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 33 run 326 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 33 run 327 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 33 run 328 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 33 run 329 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 33 run 330 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 34 run 331 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 34 run 332 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 34 run 333 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 34 run 334 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 34 run 335 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 34 run 336 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 34 run 337 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 34 run 338 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 34 run 339 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 34 run 340 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 35 run 341 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 35 run 342 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 35 run 343 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 35 run 344 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 35 run 345 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 35 run 346 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 35 run 347 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 35 run 348 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 35 run 349 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 35 run 350 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 36 run 351 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 36 run 352 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 36 run 353 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 36 run 354 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 36 run 355 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 36 run 356 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 36 run 357 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 36 run 358 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 36 run 359 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 36 run 360 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 37 run 361 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 37 run 362 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 37 run 363 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 37 run 364 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 37 run 365 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 37 run 366 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 37 run 367 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 37 run 368 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 37 run 369 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 37 run 370 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 38 run 371 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 38 run 372 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 38 run 373 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 38 run 374 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 38 run 375 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 38 run 376 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 38 run 377 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 38 run 378 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 38 run 379 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 38 run 380 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 39 run 381 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 39 run 382 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 39 run 383 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 39 run 384 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 39 run 385 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 39 run 386 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 39 run 387 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 39 run 388 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 39 run 389 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 39 run 390 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease -Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 40 run 391 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 0 72 female Normal -Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 40 run 392 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 0 40 run 393 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 0 72 female Normal -Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 40 run 394 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 4 91 female Alzheimer's Disease -Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 40 run 395 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 4 95 female Alzheimer's Disease -Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 1 C 40 run 396 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 4 84 female Alzheimer's Disease -Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 not avilable 40 run 397 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 2 85 female Normal -Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 1 B 40 run 398 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 2 92 female Normal -Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 not avilable 40 run 399 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 1 88 male Normal -Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 1 C 40 run 400 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 4 94 male Alzheimer's Disease \ No newline at end of file +source name characteristics[organism] characteristics[organism part] characteristics[organism part] characteristics[cell type] characteristics[age] characteristics[ancestry category] characteristics[sex] characteristics[disease] characteristics[developmental stage] characteristics[BRAAK] characteristics[Age at Death] characteristics[biological replicate] comment[Amyloid stage] characteristics[individual] assay name technology type comment[proteomexchange accession number] comment[data file] comment[file uri] comment[fraction identifier] comment[instrument] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[label] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] factor value[sex] factor value[disease] +Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 1 run 1 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 1 run 2 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 1 run 3 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 1 run 4 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 1 run 5 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 1 run 6 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 1 run 7 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 1 run 8 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 1 run 9 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 1 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 1 run 10 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw 1 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 2 run 11 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 2 run 12 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 2 run 13 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 2 run 14 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 2 run 15 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 2 run 16 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 2 run 17 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 2 run 18 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 2 run 19 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 2 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 2 run 20 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw 2 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 3 run 21 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 3 run 22 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 3 run 23 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 3 run 24 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 3 run 25 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 3 run 26 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 3 run 27 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 3 run 28 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 3 run 29 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 3 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 3 run 30 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw 3 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 4 run 31 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 4 run 32 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 4 run 33 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 4 run 34 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 4 run 35 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 4 run 36 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 4 run 37 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 4 run 38 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 4 run 39 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 4 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 4 run 40 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw 4 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 5 run 41 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 5 run 42 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 5 run 43 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 5 run 44 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 5 run 45 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 5 run 46 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 5 run 47 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 5 run 48 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 5 run 49 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 5 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 5 run 50 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw 5 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 6 run 51 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 6 run 52 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 6 run 53 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 6 run 54 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 6 run 55 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 6 run 56 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 6 run 57 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 6 run 58 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 6 run 59 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 6 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 6 run 60 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw 6 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 7 run 61 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 7 run 62 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 7 run 63 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 7 run 64 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 7 run 65 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 7 run 66 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 7 run 67 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 7 run 68 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 7 run 69 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 7 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 7 run 70 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw 7 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 8 run 71 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 8 run 72 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 8 run 73 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 8 run 74 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 8 run 75 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 8 run 76 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 8 run 77 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 8 run 78 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 8 run 79 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 8 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 8 run 80 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw 8 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 9 run 81 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 9 run 82 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 9 run 83 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 9 run 84 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 9 run 85 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 9 run 86 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 9 run 87 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 9 run 88 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 9 run 89 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 9 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 9 run 90 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw 9 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 10 run 91 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 10 run 92 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 10 run 93 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 10 run 94 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 10 run 95 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 10 run 96 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 10 run 97 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 10 run 98 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 10 run 99 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 10 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 10 run 100 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw 10 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 11 run 101 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 11 run 102 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 11 run 103 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 11 run 104 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 11 run 105 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 11 run 106 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 11 run 107 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 11 run 108 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 11 run 109 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 11 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 11 run 110 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw 11 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 12 run 111 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 12 run 112 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 12 run 113 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 12 run 114 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 12 run 115 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 12 run 116 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 12 run 117 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 12 run 118 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 12 run 119 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 12 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 12 run 120 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw 12 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 13 run 121 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 13 run 122 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 13 run 123 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 13 run 124 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 13 run 125 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 13 run 126 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 13 run 127 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 13 run 128 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 13 run 129 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 13 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 13 run 130 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw 13 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 14 run 131 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 14 run 132 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 14 run 133 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 14 run 134 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 14 run 135 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 14 run 136 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 14 run 137 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 14 run 138 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 14 run 139 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 14 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 14 run 140 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw 14 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 15 run 141 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 15 run 142 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 15 run 143 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 15 run 144 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 15 run 145 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 15 run 146 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 15 run 147 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 15 run 148 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 15 run 149 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 15 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 15 run 150 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw 15 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 16 run 151 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 16 run 152 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 16 run 153 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 16 run 154 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 16 run 155 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 16 run 156 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 16 run 157 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 16 run 158 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 16 run 159 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 16 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 16 run 160 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw 16 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 17 run 161 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 17 run 162 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 17 run 163 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 17 run 164 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 17 run 165 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 17 run 166 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 17 run 167 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 17 run 168 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 17 run 169 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 17 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 17 run 170 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw 17 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 18 run 171 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 18 run 172 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 18 run 173 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 18 run 174 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 18 run 175 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 18 run 176 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 18 run 177 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 18 run 178 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 18 run 179 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 18 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 18 run 180 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw 18 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 19 run 181 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 19 run 182 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 19 run 183 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 19 run 184 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 19 run 185 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 19 run 186 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 19 run 187 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 19 run 188 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 19 run 189 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 19 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 19 run 190 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw 19 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 20 run 191 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 20 run 192 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 20 run 193 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 20 run 194 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 20 run 195 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 20 run 196 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 20 run 197 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 20 run 198 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 20 run 199 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 27 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 20 run 200 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw 27 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 21 run 201 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 21 run 202 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 21 run 203 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 21 run 204 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 21 run 205 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 21 run 206 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 21 run 207 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 21 run 208 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 21 run 209 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 28 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 21 run 210 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw 28 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 22 run 211 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 22 run 212 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 22 run 213 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 22 run 214 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 22 run 215 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 22 run 216 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 22 run 217 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 22 run 218 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 22 run 219 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 29 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 22 run 220 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw 29 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 23 run 221 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 23 run 222 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 23 run 223 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 23 run 224 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 23 run 225 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 23 run 226 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 23 run 227 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 23 run 228 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 23 run 229 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 30 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 23 run 230 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw 30 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 24 run 231 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 24 run 232 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 24 run 233 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 24 run 234 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 24 run 235 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 24 run 236 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 24 run 237 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 24 run 238 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 24 run 239 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 31 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 24 run 240 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw 31 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 25 run 241 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 25 run 242 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 25 run 243 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 25 run 244 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 25 run 245 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 25 run 246 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 25 run 247 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 25 run 248 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 25 run 249 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 36 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 25 run 250 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw 36 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 26 run 251 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 26 run 252 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 26 run 253 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 26 run 254 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 26 run 255 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 26 run 256 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 26 run 257 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 26 run 258 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 26 run 259 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 37 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 26 run 260 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw 37 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 27 run 261 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 27 run 262 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 27 run 263 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 27 run 264 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 27 run 265 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 27 run 266 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 27 run 267 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 27 run 268 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 27 run 269 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 38 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 27 run 270 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw 38 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 28 run 271 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 28 run 272 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 28 run 273 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 28 run 274 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 28 run 275 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 28 run 276 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 28 run 277 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 28 run 278 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 28 run 279 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 39 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 28 run 280 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw 39 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 29 run 281 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 29 run 282 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 29 run 283 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 29 run 284 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 29 run 285 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 29 run 286 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 29 run 287 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 29 run 288 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 29 run 289 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 40 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 29 run 290 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw 40 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 30 run 291 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 30 run 292 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 30 run 293 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 30 run 294 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 30 run 295 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 30 run 296 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 30 run 297 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 30 run 298 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 30 run 299 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 41 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 30 run 300 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw 41 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 31 run 301 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 31 run 302 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 31 run 303 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 31 run 304 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 31 run 305 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 31 run 306 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 31 run 307 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 31 run 308 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 31 run 309 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 42 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 31 run 310 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw 42 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 32 run 311 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 32 run 312 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 32 run 313 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 32 run 314 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 32 run 315 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 32 run 316 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 32 run 317 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 32 run 318 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 32 run 319 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 50 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 32 run 320 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw 50 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 33 run 321 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 33 run 322 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 33 run 323 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 33 run 324 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 33 run 325 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 33 run 326 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 33 run 327 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 33 run 328 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 33 run 329 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 51 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 33 run 330 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw 51 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 34 run 331 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 34 run 332 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 34 run 333 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 34 run 334 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 34 run 335 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 34 run 336 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 34 run 337 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 34 run 338 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 34 run 339 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 52 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 34 run 340 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw 52 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 35 run 341 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 35 run 342 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 35 run 343 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 35 run 344 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 35 run 345 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 35 run 346 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 35 run 347 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 35 run 348 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 35 run 349 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 53 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 35 run 350 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw 53 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 36 run 351 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 36 run 352 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 36 run 353 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 36 run 354 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 36 run 355 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 36 run 356 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 36 run 357 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 36 run 358 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 36 run 359 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 64 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 36 run 360 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw 64 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 37 run 361 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 37 run 362 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 37 run 363 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 37 run 364 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 37 run 365 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 37 run 366 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 37 run 367 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 37 run 368 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 37 run 369 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 65 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 37 run 370 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw 65 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 38 run 371 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 38 run 372 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 38 run 373 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 38 run 374 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 38 run 375 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 38 run 376 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 38 run 377 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 38 run 378 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 38 run 379 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 66 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 38 run 380 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw 66 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 39 run 381 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 39 run 382 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 39 run 383 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 39 run 384 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 39 run 385 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 39 run 386 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 39 run 387 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 39 run 388 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 39 run 389 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 71 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 39 run 390 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw 71 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease +Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 not avilable 40 run 391 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT126 0.02 Da 10 ppm 1 female Normal +Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 40 run 392 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 0 72 1 0 40 run 393 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT127N 0.02 Da 10 ppm 1 female Normal +Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 91 1 C 40 run 394 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 95 1 C 40 run 395 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT128N 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Alzheimer's Disease not available 4 84 1 C 40 run 396 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129C 0.02 Da 10 ppm 1 female Alzheimer's Disease +Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 85 1 not avilable 40 run 397 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT129N 0.02 Da 10 ppm 1 female Normal +Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available female Normal not available 2 92 1 B 40 run 398 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130C 0.02 Da 10 ppm 1 female Normal +Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available male Normal not available 1 88 1 not avilable 40 run 399 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT130N 0.02 Da 10 ppm 1 male Normal +Sample 72 Homo sapiens Brain Hippocampus not applicable not available not available male Alzheimer's Disease not available 4 94 1 C 40 run 400 proteomic profiling by mass spectrometry PXD014557 GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw 72 AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin TMT131 0.02 Da 10 ppm 1 male Alzheimer's Disease \ No newline at end of file diff --git a/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv b/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv index 30214d21..a928e278 100644 --- a/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv +++ b/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv @@ -1,14 +1,14 @@ source name characteristics[biological replicate] characteristics[organism] characteristics[organism part] characteristics[age] characteristics[ancestry category] characteristics[cell type] characteristics[disease] characteristics[cell line] characteristics[phenotype] characteristics[genetic modification] characteristics[individual] characteristics[sex] characteristics[pooled sample] characteristics[xenograft] characteristics[enrichment process] assay name technology type comment[proteomexchange accession number] comment[cleavage agent details] comment[cleavage agent details] comment[cleavage agent details] comment[fraction identifier] comment[fragment mass tolerance] comment[instrument] comment[label] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[precursor mass tolerance] comment[technical replicate] comment[tool metadata] comment[data file] factor value[genetic modification] factor value[phenotype] -D-HEp3 #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 1 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 180615_554_AN_D1.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 2 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 180615_554_AN_D2.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -T-HEp3 #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 3 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 180615_554_AN_T1.raw not applicable NT=proliferating cells;AC=CMPO:0000241 -T-HEp3 #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 4 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 180615_554_AN_T2.raw not applicable NT=proliferating cells;AC=CMPO:0000241 -T-HEp3 #4 3 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 5 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 180615_554_AN_T4.raw not applicable NT=proliferating cells;AC=CMPO:0000241 -D-HEp3 shCTRL #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 6 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NabaC0-2-10X.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shCTRL #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 7 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NabaC1-1-10X.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shCTRL #3 3 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 8 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 Naba-1-10x_180123194318.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shCTRL #4 4 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 9 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 Naba-2-10x.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shDDR1 #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 10 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NabaSh2-4-10X.raw NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shDDR1 #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 11 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NabaSh3-2-10X.raw NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shDDR1 #3 3 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 12 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 Naba-3-10x.raw NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shDDR1 #4 4 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 13 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 Naba-4-10x.raw NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 \ No newline at end of file +D-HEp3 #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 1 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 180615_554_AN_D1.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 2 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 180615_554_AN_D2.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +T-HEp3 #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 3 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 180615_554_AN_T1.raw not applicable NT=proliferating cells;AC=CMPO:0000241 +T-HEp3 #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 4 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 180615_554_AN_T2.raw not applicable NT=proliferating cells;AC=CMPO:0000241 +T-HEp3 #4 3 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 5 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 180615_554_AN_T4.raw not applicable NT=proliferating cells;AC=CMPO:0000241 +D-HEp3 shCTRL #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 6 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NabaC0-2-10X.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shCTRL #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 7 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NabaC1-1-10X.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shCTRL #3 3 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 8 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 Naba-1-10x_180123194318.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shCTRL #4 4 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 9 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 Naba-2-10x.raw not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shDDR1 #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 10 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NabaSh2-4-10X.raw NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shDDR1 #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 11 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NabaSh3-2-10X.raw NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shDDR1 #3 3 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 12 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 Naba-3-10x.raw NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shDDR1 #4 4 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 13 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 not applicable 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 Naba-4-10x.raw NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 \ No newline at end of file diff --git a/annotated-projects/PXD023707/PXD023707.sdrf.tsv b/annotated-projects/PXD023707/PXD023707.sdrf.tsv index cb8c52bc..45535be7 100644 --- a/annotated-projects/PXD023707/PXD023707.sdrf.tsv +++ b/annotated-projects/PXD023707/PXD023707.sdrf.tsv @@ -1,4 +1,4 @@ source name characteristics[biological replicate] characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[age] characteristics[ancestry category] characteristics[sex] characteristics[disease] characteristics[individual] characteristics[enrichment process] assay name technology type comment[cleavage agent details] comment[cleavage agent details] comment[cleavage agent details] comment[fractionation method] comment[fraction identifier] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[instrument] comment[label] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[tool metadata] comment[file uri] comment[data file] factor value[disease] -fallopian tube sample 1 homo sapiens fallopian tube fallopian tube ciliated cell 43Y caucasian F cancer or benign tumor 1 NT= Extraction purification;AC=NCIT:C113061 run 1 proteomic profilling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.20 Da 10 ppm 1 NT=Q Exactive HF;AC=MS:1002523 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N','Q NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M,K,P NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110 NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805 lesSDRF v0.1.0 https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201009_MSC419_1.raw 20201009_MSC419_1.raw cancer or benign tumor -fallopian tube sample 1 homo sapiens fallopian tube fallopian tube ciliated cell 43Y caucasian F cancer or benign tumor 1 NT= Extraction purification;AC=NCIT:C113061 run 2 proteomic profilling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.20 Da 10 ppm 2 NT=Q Exactive HF;AC=MS:1002523 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N','Q NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M,K,P NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110 NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805 lesSDRF v0.1.0 https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201114_MSC419_1-2.raw 20201114_MSC419_1-2.raw cancer or benign tumor -fallopian tube sample 1 homo sapeins fallopian tube fallopian tube ciliated cell 43Y caucasian F cancer or benign tumor 1 NT= Extraction purification;AC=NCIT:C113061 run 3 proteomic profilling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.20 Da 10 ppm 3 NT=Q Exactive HF;AC=MS:1002523 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N','Q NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M,K,P NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110 NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805 lesSDRF v0.1.0 https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201114_MSC419_1-3.raw 20201114_MSC419_1-3.raw cancer or benign tumor \ No newline at end of file +fallopian tube sample 1 homo sapiens fallopian tube fallopian tube ciliated cell 43Y caucasian F cancer or benign tumor 1 NT= Extraction purification;AC=NCIT:C113061 run 1 proteomic profilling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.20 Da 10 ppm 1 NT=Q Exactive HF;AC=MS:1002523 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N','Q NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M,K,P NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110 NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805 lesSDRF v0.1.0 https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201009_MSC419_1.raw 20201009_MSC419_1.raw cancer or benign tumor +fallopian tube sample 1 homo sapiens fallopian tube fallopian tube ciliated cell 43Y caucasian F cancer or benign tumor 1 NT= Extraction purification;AC=NCIT:C113061 run 2 proteomic profilling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.20 Da 10 ppm 2 NT=Q Exactive HF;AC=MS:1002523 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N','Q NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M,K,P NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110 NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805 lesSDRF v0.1.0 https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201114_MSC419_1-2.raw 20201114_MSC419_1-2.raw cancer or benign tumor +fallopian tube sample 1 homo sapeins fallopian tube fallopian tube ciliated cell 43Y caucasian F cancer or benign tumor 1 NT= Extraction purification;AC=NCIT:C113061 run 3 proteomic profilling by mass spectrometry NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002921 not applicable not applicable 0.20 Da 10 ppm 3 NT=Q Exactive HF;AC=MS:1002523 label free sample NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N','Q NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M,K,P NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110 NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805 lesSDRF v0.1.0 https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201114_MSC419_1-3.raw 20201114_MSC419_1-3.raw cancer or benign tumor \ No newline at end of file